Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seagen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
How To Invest In The Healthcare Sector
August 19, 2023
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how...
Via
Talk Markets
Seagen's Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa's Current Market
August 16, 2023
Earlier today, Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla)...
Via
Benzinga
Win For Pfizer? Seagen's Cancer Combo Therapy Hits Primary Goal In Late-Stage Breast Cancer Study
August 16, 2023
Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla) met its...
Via
Benzinga
Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
August 16, 2023
From
Seagen Inc.
Via
Business Wire
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,600 Today
August 10, 2023
Via
Benzinga
Seagen Earnings Preview
August 01, 2023
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $17,000 Today
July 31, 2023
Via
Benzinga
3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
August 11, 2023
Robust pipelines make these three pharmaceutical stocks solid choices for investors looking for stocks to buy and hold for long-term gains
Via
MarketBeat
Exposures
COVID-19
3 Cheap Long-Term Stocks That Smart Investors Will Snap Up Now
August 06, 2023
These cheap long-term stocks are a good way to play the current market uncertainty and round out your portfolio.
Via
InvestorPlace
Seagen Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum
August 02, 2023
From
Seagen Inc.
Via
Business Wire
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of
Via
Benzinga
How Is The Market Feeling About Seagen?
July 19, 2023
Via
Benzinga
$100 Invested In Seagen 10 Years Ago Would Be Worth This Much Today
July 10, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Seagen Stock In The Last 20 Years
June 23, 2023
Via
Benzinga
3 Undervalued Large-Cap Stocks That Won't Be for Long
July 20, 2023
Buying undervalued stocks that have unrealized catalysts will rarely disappoint investors who have the discipline to hold them over time.
Via
MarketBeat
Exposures
COVID-19
"Rule Breaker Investing" Market Cap Game Show: A Battle of Wits
July 15, 2023
Sometimes you know the market cap, sometimes you're just guessing.
Via
The Motley Fool
3 Pharma Stocks That AI is Loving in July
July 13, 2023
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.
Via
InvestorPlace
3 Healthcare Stocks With Healthy Dividends
July 13, 2023
These pharmaceutical companies all combine relatively high dividends with safe payout ratios.
Via
The Motley Fool
Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023
July 12, 2023
From
Seagen Inc.
Via
Business Wire
Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout
July 11, 2023
Activision stock rocketed after a court allowed Microsoft to proceed with its $69 billion acquisition of the video game publisher.
Via
Investor's Business Daily
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...
Via
Benzinga
Best Under-the-Radar Stocks: 3 That AI Predicts Will Soar in July
July 04, 2023
Bard outperformed other AI models and even beat a human reporter in stock picking. It believes these under-the-radar stocks will soar in July.
Via
InvestorPlace
The 7 Most Undervalued S&P 500 Stocks to Buy Now
July 02, 2023
Undervalued S&P 500 stocks offer the stability of a well-established share at discount prices investors appreciate.
Via
InvestorPlace
Activision Blizzard Shares up 1.83% Amid Regulators' Blunders
June 27, 2023
Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials
June 26, 2023
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
Via
MarketBeat
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
June 20, 2023
Via
Benzinga
Phase 3 Trial of ADCETRIS® (brentuximab vedotin) with Modified Chemo Regimen Shows Non-Inferiority with Unprecedented 3-Year Progression Free Survival of 94.9% vs Less Tolerable International Standard of Care in Advanced Classical Hodgkin Lymphoma
June 20, 2023
From
Seagen Inc.
Via
Business Wire
3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever
June 20, 2023
Here are three long-term biotech stock investments that have the opportunity to turn risk -tolerant investors into millionaires.
Via
InvestorPlace
Unlock the Potential of These 7 Cash-Flow Machines
June 18, 2023
Here are seven high cash flow stocks that provide investors with both growth and value under any economic conditions.
Via
InvestorPlace
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.